Verrica Pharmaceuticals Inc.

$VRCA is up about 50% at the time of posting due to news that its partner, Torii Pharmaceutical, reported positive results from its Phase 3 trial of its treatment for molluscum contagiosum

Share this article:

About the Author:

Verrica Pharmaceuticals Inc.

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup